Nexalin Technology, Inc.
Nasdaq: NXL
- Raised $501,705 (2011)
- 1 clinical trial, 1 active
- FDA-cleared or approved devices
- Founded 2010
Life science companies
Explore 12,266 biotech, pharmaceutical, medical device, CRO and CDMO companies. Filter by type, location, clinical trials, funding, FDA registrations and research focus, then see the insights or the map. Free, and new companies are added every day.
Itamar Medical Ltd.
- Raised $15 million (2019)
- FDA-cleared or approved devices
Pulmonx Corp
Nasdaq: LUNG
- 13 clinical trials, 3 active
- FDA-cleared or approved devices
Gentuity LLC
- 4 clinical trials, 2 active
- FDA-cleared or approved devices
- Research grants: $3.4 million
Acura Pharmaceuticals, Inc
- Raised $4 million (2017)
- 4 clinical trials
- Research grants: $299,694
Artiva Biotherapeutics, Inc.
Nasdaq: ARTV
- Raised $120 million (2021)
- 6 clinical trials, 3 active
- Founded 2019
aTYR PHARMA INC
Nasdaq: ATYR
- Raised $46 million (2017)
- 9 clinical trials, 1 active
Genomind, Inc.
- Raised $6.4 million (2021)
- 4 clinical trials
- Research grants: $799,186
- Founded 2014
Gradalis, Inc.
- Raised $13 million (2025)
- 15 clinical trials, 1 active
- Research grants: $1.1 million
- Founded 2014
Molecular Templates, Inc.
- Raised $20 million (2023)
- 9 clinical trials
Monte Rosa Therapeutics, Inc.
Nasdaq: GLUE
- Raised $95 million (2021)
- 4 clinical trials, 3 active
- Founded 2019
Standard Biotools Inc.
Nasdaq: LAB
- Raised $77 million (2014)
- Research grants: $2.3 million
- Founded 2007
Zogenix, Inc.
- Raised $15 million (2010)
- 19 clinical trials, 1 active
- Founded 2006
Noctrix Health
- 9 clinical trials, 4 active
- FDA-cleared or approved devices
- Research grants: $7.8 million
Orasure Technologies Inc
Nasdaq: OSUR
- FDA-cleared or approved devices
- Research grants: $145,915
ReNovo, Inc.
- Raised $4 million (2018)
- 30 clinical trials
- FDA-cleared or approved devices
- Founded 2015
Aerie Pharmaceuticals Inc
- Raised $125 million (2014)
- 36 clinical trials
G.I. Windows, Inc.
- Raised $34 million (2024)
- 13 clinical trials, 5 active
- FDA-cleared or approved devices
- Founded 2012
Nephros Inc
Nasdaq: NEPH
- Raised $2.1 million (2021)
- FDA-cleared or approved devices
REVA Medical, Inc.
- 6 clinical trials, 1 active
- 1 FDA-registered device site
- Research grants: $150,000
Vivos Therapeutics, Inc.
Nasdaq: VVOS
- Raised $50,000 (2020)
- FDA-cleared or approved devices
- Founded 2016
Aegerion Pharmaceuticals, Inc.
- Raised $18 million (2010)
- 17 clinical trials
- Founded 2005
Aptose Biosciences Inc.
- Raised $28 million (2014)
- 8 clinical trials, 1 active
Cala Health, Inc.
- Raised $48 million (2024)
- 8 clinical trials
- FDA-cleared or approved devices
- Founded 2013
Coapt LLC
- 2 clinical trials
- FDA-cleared or approved devices
- Research grants: $7.1 million
Kiyatec Inc.
- Raised $250,000 (2024)
- 1 clinical trial
- Research grants: $7.6 million
Loxo Oncology, Inc.
- Raised $24 million (2014)
- 54 clinical trials, 11 active
- Founded 2013
PEEL Therapeutics, Inc
- Raised $9.3 million (2019)
- 1 clinical trial, 1 active
- Research grants: $1.2 million
- Founded 2015
ReNetX Bio, Inc.
- Raised $2.8 million (2020)
- 1 clinical trial
- Research grants: $6.4 million
- Founded 2009
Amphastar Pharmaceuticals, Inc.
Nasdaq: AMPH
- 21 clinical trials
- 1 FDA-registered drug site
Young Innovations Inc
- FDA-cleared or approved devices
- 1 FDA-registered drug site
Blueprint Medicines Corp
- Raised $50 million (2014)
- 35 clinical trials, 8 active
OncoC4, Inc.
- Private funding (2021)
- 10 clinical trials, 8 active
- Research grants: $4 million
- Founded 2020
Restorear Devices LLC
- 4 clinical trials, 4 active
- 1 FDA-registered device site
- Research grants: $9.8 million
Abilitech Medical, Inc.
- Raised $2.9 million (2021)
- 3 clinical trials
- Research grants: $479,604
- Founded 2016
Avenue Therapeutics, Inc.
OTC: ATXI
- Raised $242,537 (2023)
- 3 clinical trials, 1 active
- Founded 2015
AyuVis Research, Inc.
- Raised $745,000 (2019)
- 1 clinical trial, 1 active
- Research grants: $8.2 million
- Founded 2018
Checkpoint Therapeutics, Inc.
- Raised $58 million (2016)
- 3 clinical trials, 1 active
- Founded 2014
Clearmind Medicine Inc.
Nasdaq: CMND
- Raised $2.4 million (2024)
- 1 clinical trial, 1 active
Elicio Therapeutics, Inc.
Nasdaq: ELTX
- Raised $6 million (2024)
- 3 clinical trials, 1 active
- Founded 2011
Eupraxia Pharmaceuticals Inc.
Nasdaq: EPRX
- Raised $1.9 million (2024)
- 3 clinical trials, 1 active
- Founded 2012
Greenwich LifeSciences, Inc.
Nasdaq: GLSI
- Raised $2.5 million (2024)
- 1 clinical trial, 1 active
Gritstone bio, Inc.
- Raised $45 million (2022)
- 7 clinical trials
GT Biopharma, Inc.
Nasdaq: GTBP
- Raised $6 million (2025)
- 1 clinical trial
InMed Pharmaceuticals Inc.
Nasdaq: INM
- Raised $6 million (2022)
- 1 clinical trial
iSpecimen Inc.
Nasdaq: ISPC
- Raised $21 million (2021)
- 3 clinical trials, 1 active
- Founded 2009
Lexaria Bioscience Corp.
Nasdaq: LEXX
- Raised $3.5 million (2025)
- 1 clinical trial
Neonc Technologies Holdings, Inc.
Nasdaq: NTHI
- Raised $5 million (2026)
- Research grants: $2.4 million
- Founded 2023
Ovid Therapeutics Inc.
Nasdaq: OVID
- Raised $26 million (2017)
- 3 clinical trials
- Founded 2014
Polyrizon Ltd.
Nasdaq: PLRZ
- Raised $3.5 million (2026)
- 1 clinical trial, 1 active
Published company profiles only; counts update daily. Data licences